FDA OKs initial plumpness drug in 13 years

<p>NEW YORK/WASHINGTON (Reuters) U.S. health regulators authorized a initial new weight-loss drug in 13 years, permitting Arena Pharmaceuticals Inc to move a Belviq tablet to marketplace as open health advocates pull for new solutions to a nations flourishing plumpness epidemic.
The Food and Drug Administration, meaningful that millions of Americans would be tempted to take weight-loss pills, had set an scarcely high bar for approvals since of reserve problems and even deaths seen with past medicines. The many notorious, famous as a fen-phen diet-drug combo, was pulled from a marketplace in 1997.
But with some two-thirds of Americans deliberate overweight or portly and a associated costs to open health and a economy skyrocketing a FDA has been underneath ascent vigour to approve a new weight-loss treatment.
It appears that a agencys perspective has strictly shifted towards not treating plumpness is a risk in and of itself, so were peac...